期刊文献+

奥美沙坦保护糖尿病db/db小鼠肾脏的研究

The study of the renoprotective effects of olmesartan in diabetic db/db mice
下载PDF
导出
摘要 目的探讨奥美沙坦对db/db小鼠ACE2-Ang-(1-7)-MasR受体轴的影响。方法将8周龄db/db小鼠(血糖>16.7mmol/L)随机分为对照组(n=12)和奥美沙坦组(n=12)。无创血压仪监测小鼠血压;收集24 h尿液检测尿白蛋白/肌酐指标,酶联免疫吸附实验(ELISA)检测血管紧张素Ⅱ和尿8-羟基脱氧鸟苷(尿8-OHdG)水平;PAS和Masson染色方法观察肾脏病理情况;Western blot检测肾脏组织AT-1R、ACE2、Ang-(1-7)-Mas R、P22-phox、P47-phox和p-Erk1/2的蛋白表达。结果与对应时间点的对照组相比,奥美沙坦组血压无明显变化,24 h尿蛋白、尿肌酐和尿8-OHdG水平降低,血管紧张素Ⅱ(Ang-Ⅱ)水平下降;肾脏病理改善;ACE2、Ang-(1-7)-MasR、p-PI3K和p-AKT的蛋白表达明显上调,AT-1R、P22-phox、P47-phox和p-Erk1/2的蛋白表达明显下调(均P<0.05)。结论奥美沙坦对糖尿病肾脏有保护作用,其机制与调节ACE2-Ang(1-7)-Mas受体轴减轻氧化应激有密切关系。 Objective To explore the effect of olmesartan in db/db mice via modulation of ACE2-Ang (1-7) -Mas receptor axis. Methods 8-week db/db mice (6 h fasting plasma glucose 〉 16.7 mmol/L) were allocated randomly into the control group (n= 12) and the olmesartan group (n = 12). The level of blood pressure was measured by non-invasive blood pressure instrument. The level of 24 h proteinuria/urine creatinine was measured by routine chemical method. The level of serum Ang-II and urinary 8-OHdG were measured with ELISA. The renal pathological changes were examined by the methods ofPAS, Masson. The expressions of AT-1R, ACE2, Ang- (1-7) -Mas R, P22-phox, P47-phox and p-Erk1/2 were detected by Western blot. Results There was no difference in the level of blood pressure. However, compared with the control group, the expression of ACE2, Ang- (1-7) -Mas R protein and the level of insulin were increased significantly in olmesartan group. Meanwhile, the level of urinary 8-OHdG, the expression of AT-1R, P22-phox, P47-phox, p-Erk1/2 and the other indexes were decreased obviously (P〈0.05). Conclusion Olmesartan protects the kidney in diabetes via modulation of ACE2-Ang- (1-7) -Mas receptor axis, thus reduces kidney oxidative stress.
出处 《老年医学与保健》 CAS 2016年第2期93-96,共4页 Geriatrics & Health Care
基金 上海市医学重点专科建设项目(ZK2015A15) 上海市浦东新区医学领先人才项目(PWR12012-05) 上海市浦东新区卫生系统重点学科建设项目(PWZx2014-11)
关键词 ACE2-Ang-(1-7)一Mas受体轴 奥美沙坦 糖尿病肾病f ACE2-Ang- (1-7) -Mas receptor axis Olmesartan Diabetic kidney disease
  • 相关文献

参考文献15

  • 1Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of diabetic kidney disease [J]. J Clin Invest, 2014, 124 (6): 2333-2340.
  • 2Khan MA, Collins AJ, Keane WF. Diabetes in the elderly popu- lation [J]. AdvRenReplaceTher, 2000, 7 (1): 32-51.
  • 3张晓丽,叶志斌.丹参在防治老年糖尿病肾病中的价值[J].老年医学与保健,2008,14(5):307-310. 被引量:9
  • 4Favre GA, Esnault VL, Van Obberghen E. Modulation of glucose metabolism by the renin-angiotensin-aldosterone system [J]. Am J Physiol Endocrinol Metab, 2015, 308 (6): E435-E449.
  • 5Wang Y, Lin C, Ren Q, et M. Astragaloside effect on TGF- β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice [J]. Int J Clin Exp Pathol, 2015, 8 (6): 6828-6834.
  • 6Li Y, Shen GS, Yu C, et al. Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat [J]. Int J Clin Exp Pathol, 2015, 8 (2): 1604-1612.
  • 7Iwanami J, Mogi M, Tsukuda K, et al. Role of angiotensm- converting enzyme 2/angiotensin- (1-7) /Mas axis m the hypot- ensive effect ofazilsartan [J]. HypertensRes, 2014, 37 (7): 616-620.
  • 8Pinheiro SV, Sim0es E Silva AC. Angiotensm converting enzyme 2, Angiotensin- (1-7), and receptor MAS axis in the kidney [J]. IntJ Hypertens, 2012, 2012: 414128.
  • 9Ingelfinger JR.Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes [J]. N Engl J Med, 2011, 364 (10): 970-971.
  • 10Kim SM, Kim YG, Jeong KH, et al. Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells[J]. PLoS One, 2012, 7(7): e39739.

二级参考文献13

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部